 
<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>MEDD Australia | Hope For Hearts – Cardiac News and Education | Activity</title>
	<link>https://staging.medd.com.au/groups/hope-for-hearts-cardiology/</link>
	<atom:link href="https://staging.medd.com.au/groups/hope-for-hearts-cardiology/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the group, Hope For Hearts – Cardiac News and Education.</description>
	<lastBuildDate>Tue, 28 Jul 2026 11:49:03 +1000</lastBuildDate>
	<generator>https://buddypress.org/?v=3.0.4</generator>
	<language>en-AU</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">267887d241b18883e923f2e7e8875210</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: The OPTION-STEMI trial has challenged the trend [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/16527/</link>
				<pubDate>Thu, 15 Jan 2026 03:09:00 +1100</pubDate>

									<content:encoded><![CDATA[<p><span>The OPTION-STEMI trial has </span><b>challenged</b><span> the trend toward immediate complete revascularisation for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, </span><b>finding it was not non-inferior to a staged approach and potentially harmful in certain subgroups.</b></p>
<p><b><u>Key Points:</u></b></p>
<ul>
<li><span>The trial <b>compared immediate intervention on&hellip;</b></span></li>
</ul>
<p><span class="activity-read-more" id="activity-read-more-16527"><a href="https://staging.medd.com.au/news-feed/p/16527/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://eurointervention.pcronline.com/article/immediate-versus-staged-complete-revascularisation-in-patients-presenting-with-stemi-and-multivessel-disease" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2026/01/Cover_248e_July2024-jpeg.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">eurointervention.pcronline.com</p><p class="activity-link-preview-title"><a href="https://eurointervention.pcronline.com/article/immediate-versus-staged-complete-revascularisation-in-patients-presenting-with-stemi-and-multivessel-disease" target="_blank" rel="nofollow">Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease | EuroIntervention</a></p><div class="activity-link-preview-excerpt"><p>Immediate vs. staged complete revascularization in STEMI patients with multivessel disease: similar 1-year outcomes, but shorter hospital stay with immediate approach.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7f40e121e11366188293df1652ca9616</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: A new study published in 2025 reveals that over 99% [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/16250/</link>
				<pubDate>Thu, 27 Nov 2025 05:58:18 +1100</pubDate>

									<content:encoded><![CDATA[<p>A new study published in 2025 reveals that over 99% of people who suffered from heart attack, stroke, or heart failure <b>had at least one of four major modifiable cardiovascular risk factors above healthy levels prior to their event.</b></p>
<p><u>Key Points:</u></p>
<ul>
<li>Cardiovascular Diseases Leading Cause: Heart failure, heart attack, and stroke remain the top causes&hellip;</li>
</ul>
<p><span class="activity-read-more" id="activity-read-more-16250"><a href="https://staging.medd.com.au/news-feed/p/16250/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jacc.org</p><p class="activity-link-preview-title"><a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.07.014" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">255a4a2d88545627b4ed73d3dea22d92</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Climate Change and Cardiovascular Disease: [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/16044/</link>
				<pubDate>Wed, 01 Oct 2025 05:58:47 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>Climate Change and Cardiovascular Disease: Rising Temperatures Driving Increased CVD Burden in Australia &#8211; </b>A national study quantifies the current and projected cardiovascular disease (CVD) burden linked to high temperatures in Australia, <b>highlighting urgent public health risks under climate change.</b></p>
<p><b><u>Key Points:</u></b></p>
<ul>
<li>CVD and Heat: CVD, Australia’s&hellip;</li>
</ul>
<p><span class="activity-read-more" id="activity-read-more-16044"><a href="https://staging.medd.com.au/news-feed/p/16044/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">academic.oup.com</p><p class="activity-link-preview-title"><a href="https://academic.oup.com/eurheartj/article/46/19/1852/8071438" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c207a90dd9d5cf269483e69f70ee9d0f</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: ACC Guidance: Weight Management Medications as [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/15570/</link>
				<pubDate>Thu, 03 Jul 2025 02:50:57 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>ACC Guidance: Weight Management Medications as First-Line for CV Risk Reduction</b></p>
<p>The American College of Cardiology (ACC) has issued new Concise Clinical Guidance, advocating for the earlier and more prominent use of modern obesity medications, such as GLP-1 and GIP agonists, in patients where weight management can significantly&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-15570"><a href="https://staging.medd.com.au/news-feed/p/15570/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.acc.org/About-ACC/Press-Releases/2025/06/20/14/11/American-College-of-Cardiology-Issues-Guidance-on-Weight-Management-Drugs" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2025/07/9E7FA8BE7B44449AB9993CC9237EF455.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">acc.org</p><p class="activity-link-preview-title"><a href="https://www.acc.org/About-ACC/Press-Releases/2025/06/20/14/11/American-College-of-Cardiology-Issues-Guidance-on-Weight-Management-Drugs" target="_blank" rel="nofollow">American College of Cardiology Issues Guidance on Weight Management Drugs - American College of Cardiology</a></p><div class="activity-link-preview-excerpt"><p>American College of Cardiology Issues Guidance on Weight Management Drugs - American College of Cardiology</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4ed327c02e077fb8cd2d1d788a2056e8</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: High-Normal Testosterone Levels Linked to Increased [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/15568/</link>
				<pubDate>Thu, 03 Jul 2025 02:40:41 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>High-Normal Testosterone Levels Linked to Increased Atrial Fibrillation Risk in Older Men</b></p>
<p>Further analysis of the Australian-led ASPREE study reveals that healthy older men with higher <b>endogenous total testosterone concentrations</b>, even within the high-normal range, have an increased risk of developing incident atrial fibrillation (AF). This&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-15568"><a href="https://staging.medd.com.au/news-feed/p/15568/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">thelancet.com</p><p class="activity-link-preview-title"><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00190-1/fulltext" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fd488ddd198abd9757ee93da9ff222e0</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Early Childhood Food Insecurity Linked to [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/15562/</link>
				<pubDate>Wed, 02 Jul 2025 04:09:45 +1000</pubDate>

									<content:encoded><![CDATA[<p><b>Early Childhood Food Insecurity Linked to Poorer Cardiovascular Health in Young Adulthood. </b><span>A cohort study indicates a significant association between <b>food insecurity experienced in early childhood</b> and <b>worse cardiovascular health outcomes in young adulthood</b>. Highlighting the critical role of early life social determinants of health,&hellip;</span></p>
<p><span class="activity-read-more" id="activity-read-more-15562"><a href="https://staging.medd.com.au/news-feed/p/15562/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2833872" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e8c500a6c1f863a373d4147f60f3cee4</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: A new JAMA study finds that adults diagnosed with type [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/15390/</link>
				<pubDate>Thu, 22 May 2025 02:34:58 +1000</pubDate>

									<content:encoded><![CDATA[<p><span>A new </span><em>JAMA</em><span> study finds that adults diagnosed with type 1 diabetes after age 40 face <b>significantly higher risks of death and cardiovascular disease</b>—often exceeding those diagnosed at younger ages. </span><span><u>Key points:</u></span></p>
<ul>
<li>
<p>Adults diagnosed after age 40 were found to have <strong>2x higher risk of death</strong> vs. type 2 diabetes and <strong>4x higher cardiovascular mortality</strong> vs.&hellip;</p>
</li>
</ul>
<p><span class="activity-read-more" id="activity-read-more-15390"><a href="https://staging.medd.com.au/news-feed/p/15390/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">academic.oup.com</p><p class="activity-link-preview-title"><a href="https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf304/8127980" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e5ef4e5bee0be254437e8cc0458080ee</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: New research suggests that intermittent fasting may [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/15283/</link>
				<pubDate>Wed, 30 Apr 2025 04:51:42 +1000</pubDate>

									<content:encoded><![CDATA[<p>New research suggests that intermittent fasting may reduce blood clot risk by boosting the production of indole-3-propionic acid from gut microorganisms, potentially lowering blood clotting factors.</p>
<p>The study involved CAD patients treated with aspirin who were randomly assigned to either the IF or ad libitum (AL) groups. The IF group was advised&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-15283"><a href="https://staging.medd.com.au/news-feed/p/15283/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">academic.oup.com</p><p class="activity-link-preview-title"><a href="https://academic.oup.com/lifemeta/article/4/2/loaf002/7989360?login=false#507994803" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d088c9e2cd7d3f95f39eb9f3be31f130</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Several antiviral drugs have been repurposed or [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/14127/</link>
				<pubDate>Sun, 13 Oct 2024 23:38:37 +1100</pubDate>

									<content:encoded><![CDATA[<p>Several antiviral drugs have been repurposed or investigated for COVID-19 treatment, with a recent review highlighting their potential cardiovascular adverse effects. <a target='_blank' href="https://www.nature.com/articles/s41401-024-01382-w" rel="nofollow">https://www.nature.com/articles/s41401-024-01382-w</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.nature.com/articles/s41401-024-01382-w" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2024/10/41401_2024_1382_Fig1_HTML.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">nature.com</p><p class="activity-link-preview-title"><a href="https://www.nature.com/articles/s41401-024-01382-w" target="_blank" rel="nofollow">Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms - Acta Pharmacologica Sinica</a></p><div class="activity-link-preview-excerpt"><p>Antiviral therapeutics have made a critical contribution in mitigating the symptoms and clinical outcomes of the coronavirus disease of 2019 (COVID-19), in which a single-stranded RNA viral pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes multi-organ injuries. Several &hellip; <a class="activity-link-preview-more" href="https://www.nature.com/articles/s41401-024-01382-w" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">959bd637e56acbdcdd536fa4e832e3b4</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Is photoplethysmography (PPG) monitoring effective [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3786/</link>
				<pubDate>Thu, 24 Aug 2023 23:38:16 +1000</pubDate>

									<content:encoded><![CDATA[<p>Is photoplethysmography (PPG) monitoring effective and accurate in determining AF in the community?</p>
<p><a target='_blank' href="https://doi.org/10.1093/ehjdh/ztad039" rel="nofollow">https://doi.org/10.1093/ehjdh/ztad039</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b45ca3ed25073a25b2350258c7faa7fc</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Heart transplants from donors after circulatory death [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3684/</link>
				<pubDate>Fri, 28 Jul 2023 01:38:49 +1000</pubDate>

									<content:encoded><![CDATA[<p>Heart transplants from donors after circulatory death were found to have similar survival rates at 6 months compared to transplants from brain-dead donors, indicating the potential efficacy and safety of circulatory-death donor hearts.</p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">nejm.org</p><p class="activity-link-preview-title"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2212438" target="_blank" rel="nofollow">Just a moment...</a></p><div class="activity-link-preview-excerpt"><p>Just a moment...</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0720002fd8d73fc48ad3d490cca1bd06</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Beta-blockers have largely been controversial in [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3644/</link>
				<pubDate>Thu, 20 Jul 2023 05:35:19 +1000</pubDate>

									<content:encoded><![CDATA[<p>Beta-blockers have largely been controversial in some patients with HF, but do they have a role in mildly reduced HF (HFmrEF) or preserved HF patients (HFpEF)?</p>
<p><a target='_blank' href="https://www.sciencedirect.com/science/article/abs/pii/S2213177923001737" rel="nofollow">https://www.sciencedirect.com/science/article/abs/pii/S2213177923001737</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">sciencedirect.com</p><p class="activity-link-preview-title"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2213177923001737" target="_blank" rel="nofollow">ScienceDirect</a></p><div class="activity-link-preview-excerpt"><p>ScienceDirect</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">40f9c66ef8df8f02cecb096be7868e46</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Does SGLT2i have a role in mildly reduced or [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3621/</link>
				<pubDate>Wed, 19 Jul 2023 01:04:51 +1000</pubDate>

									<content:encoded><![CDATA[<p>Does SGLT2i have a role in mildly reduced or preserved HF?</p>
<p>Review the findings: <a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2804311" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/fullarticle/2804311</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2804311" target="_blank"><img src="https://cdn.jamanetwork.com/ama/content_public/journal/cardiology/939173/hoi230016f1_1686672869.74717.png?Expires=2147483647&#038;Signature=JJFIpqp~KA1DGf9U0ZxrU2CPTP2mmYi8TewwbyTJXiy7l4buTW-blSFDvhFWmBnkxMf~fXqm35TUyqI16ihkBk51vK6LtCmUwDE4VL~EiN7~JcnVQUAkLqWNhnRGfSPczzTM8kyW7rF-GPtVEdKyJrPiJ4qe5SG0EwsS7P4mHTbTJ9TNSb36cOgV6pahOEiyiq0M3grCIxzSW6ZLxYb8VrC3b~2NOnxz5ERQ9Lf6N8BtA7L3mDsJx4wOKRpCRqA69tYdmvpxaggjXyryhLI9Q6Pxs029B68QR~4KbE152w0soeG76DMe0Gs5nv~s8wG0zAsAWQYo-2TCng7YEc2znw__&#038;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2804311" target="_blank" rel="nofollow">Dapagliflozin and Total HF Events in Patients With HF With Mildly Reduced or Preserved Ejection Fraction</a></p><div class="activity-link-preview-excerpt"><p>This prespecified analysis of the DELIVER trial evaluates the effect of dapagliflozin on total (ie, first and recurrent) heart failure (HF) events and cardiovascular death among patients with HF with mildly reduced or preserved ejection fraction.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f370409e65151a4c476a25d2ad833973</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Are you up-to-date on the new hypertension guidelines? [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3605/</link>
				<pubDate>Mon, 17 Jul 2023 02:23:37 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are you up-to-date on the new hypertension guidelines? Click here to review: <a target='_blank' href="https://www.aafp.org/news/health-of-the-public/aafp-hypertension-guideline.html" rel="nofollow">https://www.aafp.org/news/health-of-the-public/aafp-hypertension-guideline.html</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.aafp.org/news/health-of-the-public/aafp-hypertension-guideline.html" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/07/hypertension-guidance800.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">aafp.org</p><p class="activity-link-preview-title"><a href="https://www.aafp.org/news/health-of-the-public/aafp-hypertension-guideline.html" target="_blank" rel="nofollow">AAFP Issues New Clinical Practice Guideline on Hypertension</a></p><div class="activity-link-preview-excerpt"><p>The AAFP’s new clinical practice guideline on hypertension gives family physicians clear, evidence-based recommendations on optimal blood pressure targets for adults with hypertension.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">44f7e451673bcdaf115b938597bc9c7a</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Should we add specific biomarkers in the search for [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3600/</link>
				<pubDate>Fri, 14 Jul 2023 07:14:48 +1000</pubDate>

									<content:encoded><![CDATA[<p>Should we add specific biomarkers in the search for patients with Heart Failure? <a target='_blank' href="https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2887" rel="nofollow">https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2887</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">32202554d92f8edab05e1c6f4a5d4b70</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: What is the effect of Albuminuria, LDL cholesterol [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3584/</link>
				<pubDate>Wed, 12 Jul 2023 02:35:04 +1000</pubDate>

									<content:encoded><![CDATA[<p>What is the effect of Albuminuria, LDL cholesterol and anaemia on CV mortality in patients with chronic kidney disease +/- diabetes?</p>
<p>Learn more: <a target='_blank' href="https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01867-8" rel="nofollow">https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01867-8</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">cardiab.biomedcentral.com</p><p class="activity-link-preview-title"><a href="https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01867-8" target="_blank" rel="nofollow">Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study - Cardiovascular Diabetology</a></p><div class="activity-link-preview-excerpt"><p>Background Cardiovascular mortality and the impact of cardiac risk factors in advanced chronic kidney disease (CKD) remain poorly investigated. We examined the risk of cardiovascular mortality in patients with advanced CKD with and without diabetes as well as the impact &hellip; <a class="activity-link-preview-more" href="https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01867-8" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0171f63d2e6d85d0db15429f6e7a3eea</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Compared to relative risk reduction, how effective [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3582/</link>
				<pubDate>Wed, 12 Jul 2023 02:29:44 +1000</pubDate>

									<content:encoded><![CDATA[<p>Compared to relative risk reduction, how effective are statins in reducing overall patient mortality?</p>
<p>View the recent study: <a target='_blank' href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055" rel="nofollow">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055" target="_blank"><img src="https://cdn.jamanetwork.com/ama/content_public/journal/intemed/938903/ioi220004f1_1650900292.52586.png?Expires=2147483647&#038;Signature=AtgCxIdT9rQZoBUiLB2xMtNwVp5lmmN6H9oqODSsd7G~D--eWOeefMm1-YEkxmy5ofrLX4EFVmerRVNLVDSzAamL6NCv3lldkoB23YNuV0sD-jRO5c6eMJLqBi-HU7UIj8y32c5iODHRThxny0XAyjOFEQopo1UujN8Oi6G-wzijbHj5iuKNpgzcmMs-Mf7yjLV0LIbkcKo79K8Tfbro9ihi2bmIWMopcDhG69RGRzab6Pr0w8h8V~x1KdF-gpGxx2OnhlhdLFW976ZLK~bk8w2BJPG4qRI5C9cQ3uoIypOrnFJfNDTeQwZrtYPOWx8Bniz1-Fklqhh9aqgCcmLk8Q__&#038;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2790055" target="_blank" rel="nofollow">Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment</a></p><div class="activity-link-preview-excerpt"><p>This systematic review and meta-analysis examines the association between absolute reductions in low-density lipoprotein cholesterol levels with treatment with statin therapy and all-cause mortality, myocardial infarction, and stroke.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">05488ecdd64b57adccd490a44c3d4e44</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: FDA grants approval for IV iron to Ferric Carboxymaltose [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3558/</link>
				<pubDate>Wed, 05 Jul 2023 07:08:13 +1000</pubDate>

									<content:encoded><![CDATA[<p class="">FDA grants approval for IV iron to Ferric Carboxymaltose in patients with heart failure.</p>
<p class="">Learn more: <a target='_blank' href="https://www.tctmd.com/news/fda-grants-first-hf-indication-iv-iron-ferric-carboxymaltose?utm_source=dlvr.it&#038;utm_medium=twitter" rel="nofollow">https://www.tctmd.com/news/fda-grants-first-hf-indication-iv-iron-ferric-carboxymaltose?utm_source=dlvr.it&#038;utm_medium=twitter</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.tctmd.com/news/fda-grants-first-hf-indication-iv-iron-ferric-carboxymaltose?utm_source=dlvr.it&#038;utm_medium=twitter" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/07/approved.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">tctmd.com</p><p class="activity-link-preview-title"><a href="https://www.tctmd.com/news/fda-grants-first-hf-indication-iv-iron-ferric-carboxymaltose?utm_source=dlvr.it&#038;utm_medium=twitter" target="_blank" rel="nofollow">FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose</a></p><div class="activity-link-preview-excerpt"><p>Both US and European guidelines support iron repletion in heart failure—regulatory support now follows.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ad1917025d5650983989df9e7040027c</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Are DOACs effective when compared to LMWH in patients [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3556/</link>
				<pubDate>Wed, 05 Jul 2023 07:04:22 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are DOACs effective when compared to LMWH in patients with cancer to prevent Venous Thromboembolism (VTE)?</p>
<p>Learn about the clinical&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-3556"><a href="https://staging.medd.com.au/news-feed/p/3556/" rel="nofollow"> Read more</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jama/article-abstract/2805894?guestAccessKey=fbb4d369-f83d-41f4-86d1-a1e5e0dc7a34&#038;utm_source=silverchair&#038;utm_medium=email&#038;utm_campaign=article_alert-jama&#038;utm_content=etoc&#038;utm_term=061323" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/07/joi230055va_1686240982.77917.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jama/article-abstract/2805894?guestAccessKey=fbb4d369-f83d-41f4-86d1-a1e5e0dc7a34&#038;utm_source=silverchair&#038;utm_medium=email&#038;utm_campaign=article_alert-jama&#038;utm_content=etoc&#038;utm_term=061323" target="_blank" rel="nofollow">DOACs vs LMWH and Recurrent VTE in Patients With Cancer</a></p><div class="activity-link-preview-excerpt"><p>This randomized trial assesses the comparative effectiveness of direct oral anticoagulants vs low-molecular-weight heparin on rate of 6-month recurrence of venous thromboembolism (VTE) among patients with cancer who had a new diagnosis of VTE.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0ff062795158eda4dfb6a33f6047c9d1</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Could mineralocorticoid receptors be a new adjunct to [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3553/</link>
				<pubDate>Tue, 04 Jul 2023 06:23:09 +1000</pubDate>

									<content:encoded><![CDATA[<p>Could mineralocorticoid receptors be a new adjunct to treat resistant hypertension?</p>
<p>View the study here: <a target='_blank' href="https://academic.oup.com/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehad299/7177582?redirectedFrom=fulltext" rel="nofollow">https://academic.oup.com/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehad299/7177582?redirectedFrom=fulltext</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d912386c468a64a8584e46f43ed1d5dc</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Does Sacubitril/Valsartan improve HF outcomes and reduce [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3528/</link>
				<pubDate>Wed, 21 Jun 2023 01:12:53 +1000</pubDate>

									<content:encoded><![CDATA[<p>Does Sacubitril/Valsartan improve HF outcomes and reduce CV risk compared to just Valsartan alone?</p>
<p>Find out more: <a target='_blank' href="https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/05/30/01/09/sacubitril-valsartan-in-heart-failure?utm_medium=social&#038;utm_source=twitter_post&#038;utm_campaign=twitter_post" rel="nofollow">https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/05/30/01/09/sacubitril-valsartan-in-heart-failure?utm_medium=social&#038;utm_source=twitter_post&#038;utm_campaign=twitter_post</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">acc.org</p><p class="activity-link-preview-title"><a href="https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/05/30/01/09/sacubitril-valsartan-in-heart-failure?utm_medium=social&#038;utm_source=twitter_post&#038;utm_campaign=twitter_post" target="_blank" rel="nofollow">Sacubitril/Valsartan in HFmrEF and HFpEF: PARAGLIDE-HF and PARAGON-HF Analyses - American College of Cardiology</a></p><div class="activity-link-preview-excerpt"><p>Marty Tam, MD, FACC</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d6173e6853b0b893dae9eea964f90b07</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Are specific SGLT2i's safe when used in conjunction [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3518/</link>
				<pubDate>Wed, 14 Jun 2023 23:33:46 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are specific SGLT2i&#8217;s safe when used in conjunction with conventional diuretics in patients with heart failure?</p>
<p>View the study: <a target='_blank' href="https://jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2023.1090" rel="nofollow">https://jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2023.1090</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f78c2872280b2d287bd1d9bea9009ba8</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Are low-dose, multi-combination antihypertensive [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3512/</link>
				<pubDate>Tue, 13 Jun 2023 02:01:52 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are low-dose, multi-combination antihypertensive therapies safe, effective, and well-tolerated in the general community?</p>
<p><span>View the study here: <a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/06/hbr230003f1_1681999274.30229.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2804313" target="_blank" rel="nofollow">Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for Hypertension</a></p><div class="activity-link-preview-excerpt"><p>This systematic review and meta-analysis evaluates the safety and efficacy of low-dose combination therapy vs monotherapy, usual care, and placebo for early treatment of hypertension.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a503b055ae3e4c78bb942a56ccd727b8</guid>
				<title>Brendon Reed posted an update in the group Hope For Hearts – Cardiac News and Education: Recently, MBS code 699 was made available to GP's [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3495/</link>
				<pubDate>Tue, 06 Jun 2023 03:53:56 +1000</pubDate>

									<content:encoded><![CDATA[<p>Recently, MBS code 699 was made available to GP&#8217;s for another 2 years. The code was introduced in May 2019 in response to increases in Cardiovascular Disease in Australia and, with the help of institutions like the Heart Foundation, quickly gained traction. Unfortunately COVID put a dampener on things before some high profile celebrities&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-3495"><a href="https://staging.medd.com.au/news-feed/p/3495/" rel="nofollow"> Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d31bcfa27c6f5fe2fd4f81d5f55aebc8</guid>
				<title>Brendon Reed posted an update in the group Hope For Hearts – Cardiac News and Education: On Friday March 25th, 2022, long time Foo Fighters [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3494/</link>
				<pubDate>Tue, 06 Jun 2023 03:52:12 +1000</pubDate>

									<content:encoded><![CDATA[<p>On Friday March 25th, 2022, long time Foo Fighters drummer Taylor Hawkins passed away from Sudden Cardiac Arrest. He was the second high profile middle aged man to pass from Cardiovascular causes in this month (the other, of course, being Shane Warne). For me this resulted in an immediate trip to the GP for a heart health assessment as it did&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-3494"><a href="https://staging.medd.com.au/news-feed/p/3494/" rel="nofollow"> Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">797e0a407e472172fa8c75b15c7863d9</guid>
				<title>Brendon Reed posted an update in the group Hope For Hearts – Cardiac News and Education: Updated to include April. Shows Low and Intermediate risk [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3485/</link>
				<pubDate>Wed, 31 May 2023 06:13:08 +1000</pubDate>

									<content:encoded><![CDATA[<p>Updated to include April. Shows Low and Intermediate risk as a percentage of all TAVI implants in ANZ (MBS figures refleting private implants only). <span class="atwho-inserted">@brendon-reed-2</span> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6195f67326be2b489cf5f401cdab0358</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Could digitoxin be used to improve outcomes in patients [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3479/</link>
				<pubDate>Tue, 30 May 2023 06:59:23 +1000</pubDate>

									<content:encoded><![CDATA[<p>Could digitoxin be used to improve outcomes in patients with heart failure?</p>
<p>Learn more: <a target='_blank' href="https://link.springer.com/article/10.1007/s00392-023-02199-z" rel="nofollow">https://link.springer.com/article/10.1007/s00392-023-02199-z</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">link.springer.com</p><p class="activity-link-preview-title"><a href="https://link.springer.com/article/10.1007/s00392-023-02199-z" target="_blank" rel="nofollow">Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial - Clinical Research in Cardiology</a></p><div class="activity-link-preview-excerpt"><p>Background The present study aimed to develop a simple dosing score when starting the cardiac glycoside digitoxin in heart failure with reduced ejection fraction (HFrEF) employing first data from the randomized, double-blinded DIGIT-HF trial. Methods and results In DIGIT-HF, digitoxin &hellip; <a class="activity-link-preview-more" href="https://link.springer.com/article/10.1007/s00392-023-02199-z" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">055211dfbcb2cf9ad0c065ce7b37be00</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Aspirin or Clopidogrel for diabetic patients with [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3463/</link>
				<pubDate>Fri, 26 May 2023 00:50:16 +1000</pubDate>

									<content:encoded><![CDATA[<p>Aspirin or Clopidogrel for diabetic patients with coronary stents, which to choose? </p>
<p><a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/05/hoi230014f1_1681134691.72181.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2803932" target="_blank" rel="nofollow">Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes</a></p><div class="activity-link-preview-excerpt"><p>This secondary analysis of the HOST-EXAM randomized clinical trial evaluates clopidogrel vs aspirin for long-term maintenance after percutaneous coronary intervention in patients with diabetes.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6d72f274587fcc4c8868b8a218678de2</guid>
				<title>Brendon Reed posted an update in the group Hope For Hearts – Cardiac News and Education: MBS Statistics up until March 2023 showing the percentage [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3455/</link>
				<pubDate>Tue, 23 May 2023 03:59:06 +1000</pubDate>

									<content:encoded><![CDATA[<p>MBS Statistics up until March 2023 showing the percentage of total TAVI implants made up by Low (38522) and Intermediate (38514) risk patients. Low risk was introduced in July 2022 and Intermediate, 3 months earlier in March. Its difficult to tell if this is a true reflection given that the numbers do not account for public implants and&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-3455"><a href="https://staging.medd.com.au/news-feed/p/3455/" rel="nofollow"> Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">323e4273efd57cf5d27416963f3cfa4d</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Stanford-led study finds sphericity as a possible [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3434/</link>
				<pubDate>Fri, 19 May 2023 02:59:58 +1000</pubDate>

									<content:encoded><![CDATA[<p>Stanford-led study finds sphericity as a possible genetic indicator of cardiac problems, despite being more common in healthy hearts than previously thought.</p>
<p>Learn more: <a target='_blank' href="https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html" rel="nofollow">https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/05/Hearts-cropped.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">med.stanford.edu</p><p class="activity-link-preview-title"><a href="https://med.stanford.edu/news/all-news/2023/03/heart-shape-predict-disease.html" target="_blank" rel="nofollow">Stanford Medicine-led study finds heart shape can predict cardiac disease</a></p><div class="activity-link-preview-excerpt"><p>While cardiac sphericity was the focus of Stanford Medicine-led research, the possibility of data science expanding the reach of biomedical science was its true core, researchers say.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d9e038ce94f883fb0751c556c23f782f</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: How do drug-eluting coronary stents compare to [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3406/</link>
				<pubDate>Mon, 15 May 2023 08:21:25 +1000</pubDate>

									<content:encoded><![CDATA[<p>How do drug-eluting coronary stents compare to drug-coated balloons in coronary vascular disease? <a target='_blank' href="https://www.jacc.org/doi/10.1016/j.jcin.2023.02.011" rel="nofollow">https://www.jacc.org/doi/10.1016/j.jcin.2023.02.011</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5a199cf782aaa23996ce60b5748f62f8</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Could there be more risk factors associated with [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3392/</link>
				<pubDate>Tue, 09 May 2023 06:51:11 +1000</pubDate>

									<content:encoded><![CDATA[<p>Could there be more risk factors associated with CVD? Perhaps inflammatory conditions may be associated with higher incidences of CVD.</p>
<p>Find out here: <a target='_blank' href="https://www.medscape.com/viewarticle/991106?ecd=mkm_ret_230429_mscpmrk-OUS_IntStories&amp;uac=356014BN&amp;impID=5370002&amp;faf=1" rel="nofollow">https://www.medscape.com/viewarticle/991106</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.medscape.com/viewarticle/991106?ecd=mkm_ret_230429_mscpmrk-OUS_IntStories&#038;uac=356014BN&#038;impID=5370002&#038;faf=1" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/05/dt_230424_businessman_chest_pain_800x450-1.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">medscape.com</p><p class="activity-link-preview-title"><a href="https://www.medscape.com/viewarticle/991106?ecd=mkm_ret_230429_mscpmrk-OUS_IntStories&#038;uac=356014BN&#038;impID=5370002&#038;faf=1" target="_blank" rel="nofollow">What New Cardiovascular Disease Risk Factors Have Emerged?</a></p><div class="activity-link-preview-excerpt"><p>The detection of new risk factors for cardiovascular disease may help reduce the incidence of this major cause of premature death and disability.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">64f11726a8f9b117f98ba81a2458e177</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Is there a higher risk of heart failure and stroke [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3365/</link>
				<pubDate>Fri, 28 Apr 2023 06:48:05 +1000</pubDate>

									<content:encoded><![CDATA[<p>Is there a higher risk of heart failure and stroke in patients with AF rates &gt; 100 bpm? How should we manage these patients?</p>
<p><a target='_blank' href="https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euad088/7135509" rel="noopener noreferrer" rel="nofollow">https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euad088/7135509</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">89e81d0a55faa3a0db31046f5175ba67</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Review the findings from this comprehensive study [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3331/</link>
				<pubDate>Mon, 24 Apr 2023 05:13:39 +1000</pubDate>

									<content:encoded><![CDATA[<p>Review the findings from this comprehensive study comparing structured diet and health behavior programs and their efficacy in preventing cardiovascular diseases and mortality among those at higher risk.</p>
<p><span>Learn more: </span><span><a target='_blank' href="https://www.bmj.com/content/380/bmj-2022-072003" rel="nofollow">https://www.bmj.com/content/380/bmj-2022-072003</a> </span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.bmj.com/content/380/bmj-2022-072003" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/04/8379.cover-source-scaled.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">bmj.com</p><p class="activity-link-preview-title"><a href="https://www.bmj.com/content/380/bmj-2022-072003" target="_blank" rel="nofollow">Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis</a></p><div class="activity-link-preview-excerpt"><p>Objective To determine the relative efficacy of structured named diet and health behaviour programmes (dietary programmes) for prevention of mortality and major cardiovascular events in patients at increased risk of cardiovascular disease. Design Systematic review and network meta-analysis of randomised &hellip; <a class="activity-link-preview-more" href="https://www.bmj.com/content/380/bmj-2022-072003" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cc8ad90bbcacaf37c3baeba2b874b983</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Should patients undergo total, single-step [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3327/</link>
				<pubDate>Sat, 22 Apr 2023 09:26:36 +1000</pubDate>

									<content:encoded><![CDATA[<p>Should patients undergo total, single-step revascularisation at initial presentation to CCL, or are the benefits higher if it is multi-staged? </p>
<p><a target='_blank' href="https://www.medscape.com/viewarticle/989106?ecd=WNL_trdalrt_pos1_ous_230308&#038;uac=356014BN&#038;impID=5225487" rel="nofollow">https://www.medscape.com/viewarticle/989106?ecd=WNL_trdalrt_pos1_ous_230308&#038;uac=356014BN&#038;impID=5225487</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.medscape.com/viewarticle/989106?ecd=WNL_trdalrt_pos1_ous_230308&#038;uac=356014BN&#038;impID=5225487" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/04/dt_230303_heart_800x450.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">medscape.com</p><p class="activity-link-preview-title"><a href="https://www.medscape.com/viewarticle/989106?ecd=WNL_trdalrt_pos1_ous_230308&#038;uac=356014BN&#038;impID=5225487" target="_blank" rel="nofollow">BIOVASC: Immediate Complete Revascularization Beneficial in ACS  </a></p><div class="activity-link-preview-excerpt"><p>Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel disease, results of the BIOVASC trial suggest.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">86d4979a9c1b7dea8cd87989d2239679</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Renal Denervation is now an accepted tool for the [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3323/</link>
				<pubDate>Thu, 20 Apr 2023 02:43:06 +1000</pubDate>

									<content:encoded><![CDATA[<p>Renal Denervation is now an accepted tool for the treatment of hypertension across the world.</p>
<p>Click here to read the latest guidelines from the European Society of Cardiology &#8211; <a target='_blank' href="https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad054/7036012" rel="nofollow">https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad054/7036012</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">afdbf9c480b0f131fa514b285523da1f</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Could pre-hospital Troponin testing be effective [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3311/</link>
				<pubDate>Mon, 17 Apr 2023 07:12:26 +1000</pubDate>

									<content:encoded><![CDATA[<p>Could pre-hospital Troponin testing be effective in improving chest pain pathways? <a target='_blank' href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009" rel="nofollow">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/04/ioi220082f1_1677616713.94137.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2801009" target="_blank" rel="nofollow">Chest Pain Management Using Prehospital Point-of-Care Troponin and Paramedic Risk Assessment</a></p><div class="activity-link-preview-excerpt"><p>This economic evaluation uses cost-minimization analysis to estimate the cost savings of paramedic risk stratification of adult acute chest pain and point-of-care troponin testing.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cf80cbc747f0583c25623b054594d70a</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Can lowering blood pressure reduce the likelihood of [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3305/</link>
				<pubDate>Fri, 14 Apr 2023 04:42:14 +1000</pubDate>

									<content:encoded><![CDATA[<p>Can lowering blood pressure reduce the likelihood of a secondary stroke? </p>
<p><a target='_blank' href="https://jamanetwork.com/journals/jamaneurology/fullarticle/2802775" rel="nofollow">https://jamanetwork.com/journals/jamaneurology/fullarticle/2802775</a> </p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5d0b6246d64069f1deda39bbfcd6a87e</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Are we closer to having an oral PCSK9 inhibitor that is [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3281/</link>
				<pubDate>Mon, 10 Apr 2023 02:02:44 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are we closer to having an oral PCSK9 inhibitor that is safe and effective?</p>
<p><a target='_blank' href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" rel="nofollow">https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/04/cholesterol-test-results_adobe.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">healio.com</p><p class="activity-link-preview-title"><a href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" target="_blank" rel="nofollow">Oral PCSK9 inhibitor lowers LDL similar to injection in short-term phase 2 trial</a></p><div class="activity-link-preview-excerpt"><p>NEW ORLEANS — In a phase 2 trial, an oral PCSK9 inhibitor lowered LDL about the same amount observed with injectable PCSK9 inhibitors for 8 weeks, researchers reported at the American College of Cardiology Scientific Session.For the phase 2b, randomized, &hellip; <a class="activity-link-preview-more" href="https://www.healio.com/news/cardiology/20230306/oral-pcsk9-inhibitor-lowers-ldl-similar-to-injection-in-shortterm-phase-2-trial" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ce96efa33ff4994db564f9ce809c97b7</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: In a HPrEF patient, can Dapagliflozin improve Hb [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3268/</link>
				<pubDate>Wed, 05 Apr 2023 01:06:37 +1000</pubDate>

									<content:encoded><![CDATA[<p>In a HPrEF patient, can Dapagliflozin improve Hb and functional capacity, QOL and NT-proBNP?</p>
<p>Find out here: <a target='_blank' href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" rel="nofollow">https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/04/gr2.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">onlinejcf.com</p><p class="activity-link-preview-title"><a href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" target="_blank" rel="nofollow">Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life, and Natriuretic Peptides after initiation of Dapagliflozin in Heart Failure with Reduced Ejection Fraction</a></p><div class="activity-link-preview-excerpt"><p>Prior studies show a significant increase in hemoglobin and hematocrit following sodium-glucose co-transporter 2 inhibitors (SGLT2i) initiation, being useful for identifying those at lower risk of adverse clinical events.1 In the DAPA-VO2 randomized clinical trial, we found that dapagliflozin significantly &hellip; <a class="activity-link-preview-more" href="https://www.onlinejcf.com/article/S1071-9164(23)00060-X/fulltext" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">83a01f5b708f3fc1b350b727c7d1ab3e</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Are we ready for wrist-worn tech to aid in confirming [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3262/</link>
				<pubDate>Mon, 03 Apr 2023 23:31:14 +1000</pubDate>

									<content:encoded><![CDATA[<p>Are we ready for wrist-worn tech to aid in confirming acute myocardial infarction?</p>
<p><span>Learn about it here: </span><span><a target='_blank' href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" rel="nofollow">https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/04/alert-on-heart-monitor.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">healio.com</p><p class="activity-link-preview-title"><a href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" target="_blank" rel="nofollow">Wrist-worn sensor shows early promise for assessing likelihood of suspected heart attack</a></p><div class="activity-link-preview-excerpt"><p>NEW ORLEANS — In a new study, use of a wrist-worn sensor was clinically feasible for rapid, bloodless prediction of elevated troponin I in patients with suspected MI, researchers reported at the American College of Cardiology Scientific Session.“Assessing high-sensitivity cardiac &hellip; <a class="activity-link-preview-more" href="https://www.healio.com/news/cardiology/20230306/wristworn-sensor-shows-early-promise-for-assessing-likelihood-of-suspected-heart-attack" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7a7ba00d1071b30338c1f0c25621a9bb</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: How well do we treat patients requiring Statins and [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3257/</link>
				<pubDate>Mon, 03 Apr 2023 02:18:26 +1000</pubDate>

									<content:encoded><![CDATA[<p>How well do we treat patients requiring Statins and other lipid-lowering drugs in the real world? <a target='_blank' href="https://academic.oup.com/ehjopen/article/2/6/oeac070/6775424" rel="noopener noreferrer" rel="nofollow">https://academic.oup.com/ehjopen/article/2/6/oeac070/6775424</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f2e953eacb26882efc40c6d8b2de4161</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Could Rivaroxaban replace Enoxaparin in patients with [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3251/</link>
				<pubDate>Thu, 30 Mar 2023 04:27:06 +1100</pubDate>

									<content:encoded><![CDATA[<p>Could Rivaroxaban replace Enoxaparin in patients with Acute Coronary Syndrome and Dual Antiplatelet Therapy?</p>
<p>Explore the findings: <a target='_blank' href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801235" rel="nofollow">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801235</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801235" target="_blank" rel="nofollow">Rivaroxaban vs Enoxaparin in Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of ACS</a></p><div class="activity-link-preview-excerpt"><p>This randomized equivalence and noninferiority trial compares safety and efficacy of enoxaparin vs rivaroxaban 2.5 or 5 mg for patients with acute coronary syndrome (ACS) in the acute phase.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3eb943bb2880dc34c0a5607e0c8d39c0</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Has the continued improvement in Atrial Fib treatments [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3206/</link>
				<pubDate>Mon, 20 Mar 2023 06:21:10 +1100</pubDate>

									<content:encoded><![CDATA[<p>Has the continued improvement in Atrial Fib treatments made a difference in patient outcomes over the past ten years?</p>
<p>View the results: <a target='_blank' href="https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15839" rel="noopener noreferrer" rel="nofollow">https://onlinelibrary.wiley.com/doi/abs/10.1111/jce.15839</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">73a9bf86480cc5f12cd5aea16b6a36fa</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Does a Self Manage Blood Pressure (SMBP) measurement [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3185/</link>
				<pubDate>Tue, 14 Mar 2023 00:41:02 +1100</pubDate>

									<content:encoded><![CDATA[<p>Does a Self Manage Blood Pressure (SMBP) measurement that automatically links with a smartphone app improve patient satisfaction compared to simple SMBP at home? </p>
<p>You may be surprised at the results: <a target='_blank' href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2794971" rel="nofollow">https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2794971</a></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2794971" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/03/ioi220045va_1674232848.06734.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2794971" target="_blank" rel="nofollow">Effectiveness of Standard vs Enhanced Self-measurement of BP Paired With a Connected Smartphone Application</a></p><div class="activity-link-preview-excerpt"><p>This randomized clinical trial explores if enhanced self-measured blood pressure (SMBP) paired with a connected smartphone application is superior to standard SMBP for blood pressure reduction or patient satisfaction.</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">95dcd108eb7e1367064d43877fdb8927</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: How common is sudden cardiac arrest in older [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3162/</link>
				<pubDate>Fri, 03 Mar 2023 02:30:05 +1100</pubDate>

									<content:encoded><![CDATA[<p>How common is sudden cardiac arrest in older patients? Should we continue to promote exercise in this group?</p>
<p>Read the original investigation: <a target='_blank' href="https://www.jacc.org/doi/abs/10.1016/j.jacep.2022.10.033" rel="nofollow">https://www.jacc.org/doi/abs/10.1016/j.jacep.2022.10.033</a></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b0d97c82bdbb5a3f58c0d1908087c258</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: What is atrial insufficiency? And what does it mean [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3095/</link>
				<pubDate>Thu, 23 Feb 2023 06:35:12 +1100</pubDate>

									<content:encoded><![CDATA[<p>What is atrial insufficiency? And what does it mean for patients? </p>
<p>Read the findings: <a target='_blank' href="https://www.sciencedirect.com/science/article/pii/S0735109719384530" rel="nofollow">https://www.sciencedirect.com/science/article/pii/S0735109719384530</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">sciencedirect.com</p><p class="activity-link-preview-title"><a href="https://www.sciencedirect.com/science/article/pii/S0735109719384530" target="_blank" rel="nofollow">ScienceDirect</a></p><div class="activity-link-preview-excerpt"><p>ScienceDirect</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bc99e6d884f19524305c04cf21d24daf</guid>
				<title>Drew Miller posted an update in the group Hope For Hearts – Cardiac News and Education: Do atrial fibrillation (AF) self-screening stations [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3086/</link>
				<pubDate>Fri, 17 Feb 2023 03:55:13 +1100</pubDate>

									<content:encoded><![CDATA[<p>Do atrial fibrillation (AF) self-screening stations in general practice waiting rooms enhance AF screening, diagnosis, and stroke risk management?</p>
<p>Learn more here: <span><a target='_blank' href="https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation" rel="nofollow">https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation</a></span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/02/mja2.51803.jpg" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">mja.com.au</p><p class="activity-link-preview-title"><a href="https://www.mja.com.au/journal/2023/218/1/increasing-screening-atrial-fibrillation-general-practice-atrial-fibrillation" target="_blank" rel="nofollow">Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self‐Screening, Management And guideline‐Recommended Therapy (AF Self‐SMART) study</a></p><div class="activity-link-preview-excerpt"><p>AF self-screening in general practice waiting rooms is feasible, and could reduce the number of AF-related strokes</p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6f5015dc110f3d26e1a45601d64771c7</guid>
				<title>Tylah McDonald posted an update in the group Hope For Hearts – Cardiac News and Education: Could there be a link between high LDL levels and [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/3054/</link>
				<pubDate>Thu, 02 Feb 2023 06:38:32 +1100</pubDate>

									<content:encoded><![CDATA[<p>Could there be a link between high LDL levels and fractures? Read the brief report: <a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308</a> </p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2023/02/hbr220011t1_1672763439.54848.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" target="_blank" rel="nofollow">Association of Plasma HDL-C Level With Risk of Fractures in Healthy Older Adults</a></p><div class="activity-link-preview-excerpt"><p>This cohort study performs a post hoc analysis of data for US and Australian participants in the Aspirin in Reducing Events in the Elderly (ASPREE) clinical trial to determine the association between level of high-density lipoprotein cholesterol and increased fracture &hellip; <a class="activity-link-preview-more" href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2800308" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8637e8f84cd8b2c77ccd7eee3dee4e00</guid>
				<title>MEDD Admin posted an update in the group Hope For Hearts – Cardiac News and Education: Do SGLT2i's improve outcomes across all LVEF? Click [&#133;]</title>
				<link>https://staging.medd.com.au/news-feed/p/2973/</link>
				<pubDate>Wed, 28 Dec 2022 00:12:53 +1100</pubDate>

									<content:encoded><![CDATA[<p>Do SGLT2i&#8217;s improve outcomes across all LVEF? Click the link to read more &#8211; <span><a target='_blank' href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2796866" rel="nofollow">https://jamanetwork.com/journals/jamacardiology/fullarticle/2796866</a> </span></p>
<div class="activity-link-preview-container"><div class="activity-link-preview-image"><div class="activity-link-preview-image-cover"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2796866" target="_blank"><img src="https://staging.medd.com.au/wp-content/uploads/2022/12/hoi220064t1_1670961375.57423.png" /></a></div></div><div class="activity-link-preview-info"><p class="activity-link-preview-link-name">jamanetwork.com</p><p class="activity-link-preview-title"><a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2796866" target="_blank" rel="nofollow">Dapagliflozin and Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction</a></p><div class="activity-link-preview-excerpt"><p>This pooled analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) and Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) trials investigates the effect of dapagliflozin on specific causes &hellip; <a class="activity-link-preview-more" href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2796866" target="_blank" rel="nofollow">Continue reading</a></p></div></div></div>]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
		